Ten hospitalized patients performed two exercise tests per day on five consecutive days to determine the efficacy and duration of action of three sublingual long-acting nitrate preparations: isosorbide dinitrate, pentaerythritol trinitrate, and erythrityl tetranitrate. The duration of exercise to the point of ischemia, manifest as typical anginal pain and/or 1.0 mm ST-segment depression, was determined 45 min and 100 min after each long-acting nitrate was administered.
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Pentaerythritol trinitrate Angina pectoris Coronary ischemia SUBLINGUAL long-acting nitrates are extensively prescribed for the symptomatic prophylaxis of angina pectoris. However, the efficacy of these preparations and their value in comparison with nitroglycerin remain controversial.1-7 Previous studies from this laboratory using a protocol of multiple exercise tests on several consecutive days have shown a high level of reproducibility.6' 8 In addition, no evidence of a training effect from using repetitive exercise tests over several days could be detected. A study was therefore undertaken using this basic protocol to compare three long-acting nitrate preparations with respect to efficacy and duration of action.
Methods

Patients
Criteria for inclusion in this study were: 1) Definite electrocardiographic evidence of myocardial ischemia during or after exercise stress testing. 2) Presence of a definable endpoint of ischemia during exercise consisting either of typical angina pain or ECG changes. 3) Absence of evidence of valvular heart disease or congestive heart failure. 4) Abstinence from digitalis preparations for at least six weeks prior to the study.
Clinical data on the ten male patients included in this study are presented in table 1 . The average age was 46; four patients had a history of myocardial infarction at least six months or more prior to the time of the study. Coronary angiography was performed in seven of the ten patients and all had proven coronary arteriosclerosis. One patient had previously undergone saphenous vein bypass surgery but was unimproved and two other patients had surgery within a month after their studies.
Protocol
All patients were admitted to a special research unit in the hospital for five days during which all cardiovascular medications were stopped except for The patients were told that they would be given a drug which might increase their exercise capacity. All medications were given sublingually and the patients were instructed to allow the tablet to completely dissolve. The protocol is outlined in table 2. One of the three long acting nitrates was given on days 2, 3, and 4 in a double-blind fashion 45 minutes prior to the first and 100 minutes before the second exercise test. The three drugs tested were isosorbide dinitrate 5 mg (ISD), erythrityl tetranitrate 10 mg (ETN), and pentaerythritol trinitrate 10 mg (PTN) . No long-acting nitrate was given on days 1 and 5; instead, the patients were given either placebo (PLAC) or nitroglycerin 0.4 mg (TNG) two minutes before exercise. Five patients received PLAC before the first exercise and TNG before the second exercise on day 1 whereas on day 5 they received TNG before the first exercise and PLAC before the second exercise. For the other five patients the sequence of days 1 and 5 was reversed. The study was not strictly double-blind in that the investigator knew that PLAC or TNG was to be administered on days 1 and 5. He did not, however, know the sequence used on days 1 and 5 nor the specific drugs on days 2, 3, and 4. After the first exercise the patients rested until the ECG returned to baseline and pain disappeared before additional drugs were given. The average time from the beginning of the first exercise to the administration of the next drug was approximately ten minutes. Blood pressure and heart rates were recorded in the supine and standing positions immediately before each exercise. It was not possible to reliably record blood pressure during exercise on the escalator ergometer. Analysis All ECG's were read and checked by at least two of the authors. Analysis of the statistical significance of differences observed in blood pressure, heart rate, and duration of exercise between PLAC, TNG, and the three long-acting nitrates was perforned using the paired t-test.
Results
The systolic blood pressures and heart rates recorded in the control setting before any drug administration are shown in table 3. There was little variation in mean control systolic blood pressure and heart rates on any of the five days.
The mean changes after drug administration from the control values on the same day in supine and standing systolic blood pressures and heart rates are shown in table 4. Since there was no difference between the changes after PLAC on day 1 and day 5, the values were combined to get a mean change after PLAC. This value was then compared with the changes in systolic blood pressure and heart rate observed after each drug. All long-acting nitrates produced a significant decrease in standing systolic blood pressure 45 min (pre-exercise 1) and 100 min (pre-exercise 2) after administration. A significant increase in standing fig. 1 ). In addition, each of three long-acting nitrates given 45 min prior to exercise prolonged exercise tolerance to a degree similar to that observed after TNG ( fig. 2) . The mean durations of exercise 100 min after each longacting nitrate were longer than after PLAC but the differences were not statistically significant ( fig. 2,  table 5 ). No significant differences were found among the three long-acting nitrates in either exercise 1 or exercise 2.
Since TNG was given immediately prior to the first exercise on one of the five days, it is possible to get some idea of the duration of its effect by looking at the duration of the second exercise on the same day (which was performed after PLAC administration). The time from administration of TNG to the start of the second exercise averaged 55 min. Since there was no difference between exercise 1 and exercise 2 after PLAC, it can be inferred that no effect of TNG at the dosage given (0.4 mg) can be seen 55 min after its administration.
Although there was no significant difference between exercise duration after PLAC and 100 min after the long-acting nitrates, examination of the individual patient data ( fig. 3) Figure 1 Exercise duration after placebo (PLAC) and two minutes after nitroglycerin (TNG). Exercise 1 (Ex 1) and Exercise 2 (Ex 2) on the first day of the protocol are compared with those on the last day. The bars depict the mean and standard error of mean for the ten patients.
individual variation in exercise duration after PLAC was found to be 17% and 11%.6, 8 Redwood et al.,9 using a bicycle ergometer, have recently shown that stress sufficient to induce angina in less than three minutes may be "super maximal" and obscure the therapeutic effects of TNG and carotid sinus stimulation whereas these same modes of therapy clearly prolong exercise tolerance at lesser work loads. Our results, both in the present study and in previous studies, 6' 8 indicate that the degree of work achieved in less than three minutes using the escalator ergometer does not obscure the effectiveness of antianginal therapy. The work load on the escalator ergometer set at 150 watts used in the present study may be Circulation, Volume XLVIII, September 1973 greater than that used by Redwood et al. It does not, however, appear that angina induced in less than three minutes on the escalator ergometer is "super maximal," as our technique is sufficiently sensitive to detect differences in effectiveness of antianginal agents. It is, however, possible that significant effects 55 min after TNG administration or 100 min after administration of the long-acting nitrates could have been demonstrated if lower intensities of exercise stress were employed. It should be pointed out that the type of laboratory exercise stress test which most closely duplicates real life daily stress has never been determined and therefore, the application of any laboratory data to the practical difficulties of managing patients must be inferential. Thus it is probably correct that with mild exercise a patient can work longer before angina than with heavy exercise, and that TNG might prolong the onset of angina in mild exercise by a greater amount than it can in heavy exercise. However, the prophylactic effect of TNG under both test situations is definite and this information can be approximately applied to individual patients. It is likely that "super maximal" exercise in a nontest environment may be as little affected by TNG as it is in the laboratory.
This study showed a significant improvement in exercise duration 45 min after administration of each of the long-acting nitrates but failed to show a significant group effect for any long-acting nitrate 100 min after administration. Even though there was no significant difference among the three sublingual long-acting nitrates in the aggregate, there was variation among individuals in their response to different long-acting nitrates. Since the long-acting nitrates were not tested at exactly the same time after administration as TNG and dose response curves were not established, the present protocol does not provide direct evidence of the comparative duration of action of TNG and the long-acting nitrates. There is, however, suggestive evidence from analysis of the individual patient responses that the effect of long-acting nitrates in the doses used in the present study may persist longer than 0.4 mg TNG. In only one of the patients was there a suggestion that TNG prolonged exercise 55 min after administration, whereas four to five of the patients ( fig. 3) obtained a therapeutic affect 100 min after the long-acting nitrate similar to that seen after 45 min.
It was notable that all long-acting nitrates produced a significant decrease in standing systolic blood pressure at both 45 and 100 min after Figure 3 Duration of exercise in individual patients 45 and 100 min after ETN, ISD, and PTN. The exercise duration after PLAC is plotted on the abscissa and compared to the exercise duration after the LAN plotted on the ordinate. The line of identity is shown for each drug. Most important, however, should be the knowledge that while these drugs do appear to be useful as prophylaxis for angina, their duration of action is really not very long. They, therefore, should probably not be given on a fixed schedule but rather should be taken by a patient whenever he anticipates that he will be in an angina-provoking situation for up to one hour. As others have pointed out, the relatively short durations of action of the long-acting nitrates may account for some of the previous failures to show therapeutic benefit in clinical trials.1' 3Finally, it should be mentioned that no drug may be able to prevent angina provoked by excessive exertion and therefore thoughtful patient counseling is still an important aspect of the care of patients with ischemic heart disease.
